AMRX
HEALTHCAREAmneal Pharmaceuticals, Inc. Class A Common Stock
AI Insight
What's Moving AMRX Today?
No stock-specific AI insight has been generated for AMRX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$7.67$16.73
$17.26
Fundamentals
Market Cap$5.3B
P/E Ratio45.0
EPS$0.37
Dividend Yield—
Dividend / Share—
ROE-881.0%
Profit Margin4.0%
Debt / Equity—
Trading
Volume1.5M
Avg Volume (10D)—
Shares Outstanding319.0M
AMRX News
22 articles- Amneal Pharmaceuticals stock hits 52-week high at 16.62 USD By Investing.comInvesting.com Canada·Jun 23, 2026
- Korro Bio, Inc. (KRRO) Soars 17.6%: Is Further Upside Left in the Stock?Yahoo Finance·Jun 19, 2026
- FDA Seeks Updated Labeling for Testosterone TherapiesYahoo Finance·Jun 18, 2026
- 1 Small-Cap Stock for Long-Term Investors and 2 We Find RiskyYahoo Finance·Jun 17, 2026
- Amneal Pharmaceuticals (AMRX) Is Up 17.8% After CREXONT Phase 4 Gains And New Oncology LaunchYahoo Finance·Jun 13, 2026
- Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?Yahoo Finance·Jun 12, 2026
- 3 Russell 2000 Stocks with Open QuestionsYahoo Finance·Jun 10, 2026
- Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal PharmaceuticalsYahoo Finance·Jun 10, 2026
- Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth PhaseMarketbeat·Jun 9, 2026
- How The Amneal Pharmaceuticals (AMRX) Story Is Shifting With Biosimilars And 2026 ExpectationsYahoo Finance·Jun 6, 2026
- Amneal Stock Up on FDA Nod for Romidepsin Injection SolutionYahoo Finance·Jun 5, 2026
- Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's DiseaseYahoo Finance·Jun 5, 2026
- Why Amneal (AMRX) Stock Is Trading Up TodayYahoo Finance·Jun 5, 2026
- 3 Profitable Stocks with Open QuestionsYahoo Finance·Jun 4, 2026
- Amneal Announces U.S. FDA Approval of Romidepsin Injection SolutionYahoo Finance·Jun 4, 2026
- Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now?Yahoo Finance·Jun 1, 2026
- Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026Yahoo Finance·Jun 1, 2026
- Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals StocksYahoo Finance·May 27, 2026
- Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?Yahoo Finance·May 26, 2026
- 3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX)Yahoo Finance·May 15, 2026
- Should Value Investors Buy Amneal Pharmaceuticals (AMRX) Stock?Yahoo Finance·May 15, 2026
- Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.GlobeNewswire Inc.·Apr 14, 2026
All 22 articles loaded
Price Data
Open$16.81
Previous Close$16.66
Day High$17.40
Day Low$16.81
52 Week High$16.73
52 Week Low$7.67
52-Week Range
$7.67$16.73
$17.26
Fundamentals
Market Cap$5.3B
P/E Ratio45.0
EPS$0.37
Dividend Yield—
Dividend / Share—
ROE-881.0%
Profit Margin4.0%
Debt / Equity—
Trading
Volume1.5M
Avg Volume (10D)—
Shares Outstanding319.0M
About Amneal Pharmaceuticals, Inc. Class A Common Stock
Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company is headquartered in Bridgewater, New Jersey.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—